TX-MARY-KAY
4.11.2021 13:14:11 CET | Business Wire | Press release
Mary Kay Inc., a leading corporate advocate of women’s empowerment and entrepreneurship, announced today its second World Series of Innovation (WSI) Challenge in partnership with Network for Teaching Entrepreneurship (NFTE). In its second year partnering with NFTE, Mary Kay is sponsoring the 2021 NFTE World Series of Innovation, a global educational experience that invites young people ages 13-24 to channel their critical thinking and problem-solving skills to find solutions for the biggest challenges facing the world today and help advance the UN Sustainable Development Goals (SDGs) while fostering an entrepreneurial mindset.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20211104005178/en/
Mary Kay’s World Series of Innovation Challenge encourages young people from around the world to submit innovative solutions to address Sustainable Development Goal 5: Gender Equality . Specifically, this challenge asks students to think about ways to promote workplace equality and ensure equal access to economic opportunity for women and girls. Pre-Covid, decades of data demonstrated the rise of women in the workforce -even though the wage gap persisted - more women were joining the labor market every year. But pandemic job losses disproportionately impacted women, and since 2020, the uphill climb to workforce equality has grown even steeper.
“Mary Kay knows the importance of entrepreneurship and the role it plays in the world today and in the future, which is why we invest annually in programs and initiatives to help empower women and girls around the world,” said Deborah Gibbins, Chief Operating Officer for Mary Kay Inc. “We want to help not only provide educational opportunities but help them pursue their dreams around the world. We are beyond excited for this challenge so connected to our company’s core mission.”
NFTE is a global educational nonprofit focused on bringing the power of entrepreneurship to youth in low-income communities. The World Series of Innovation (WSI) Challenge invites corporate sponsored challenges to address the UN Sustainable Development Goals. With a reach of 100,000 students worldwide, in 2020, NFTE received nearly 4,000 student participants of all backgrounds submitting ideas in the WSI Challenges and nearly 350 students participated in the first-ever Mary Kay-sponsored challenge to address Sustainable Development Goal 12: Responsible Consumption and Production. The three winners of Mary Kay’s 2020 Challenge were:
-
First Place: Loop Tee Loop
- Loop Tee Loop is a sustainable clothing loop uniting lyocell textile mills with uniform recycling collection services from Metro Manila in the Philippines.
-
Second Place: SwagSwap
- SwagSwap is a US-based social network for thrifting, enabling peer-to-peer clothing swap for teens.
-
Third Place: Project DBrand
- Project DBrand is a unique service that de-brands used uniforms so they can be upcycled based in the US.
“Supporting the entrepreneurial development of young people is critical to help build a better world for future generations,” said J.D. LaRock, President and Chief Executive Officer of NFTE. “Each year, we continue to be inspired by the innovations the next generation of entrepreneurs envision, and we look forward to seeing all the new ideas from WSI competitors in 2021. We are grateful to Mary Kay Inc. for its support for the second year posing this critical global challenge to help advance workplace equality and achieve equal access to economic opportunity for women and girls.”
In addition to the World Series of Innovation, Mary Kay supported NFTE’s Entrepreneurship in Every School program, bringing the entrepreneurial journey through curriculum to students across the U.S. and internationally; and sponsored NFTE’s Regional Youth Entrepreneurship Challenges where students pitch business opportunities for seed money in a competitive setting.
The 2021 NFTE World Series of Innovation is presented by Citi Foundation and features challenges from Bank of the West, Citi Foundation, Ernst & Young LLP (EY US), Mary Kay, Inc., Maxar Technologies, PIMCO, and Saint-Gobain. Challenges launched on September 15th and entries are due by December 15th . Judging begins in January of 2022. Finalists will be announced in February and winners will be announced on March 31st .
For more information about the World Series of Innovation and all challenges, visit https://innovation.nfte.com
About Mary Kay
One of the original glass ceiling breakers, Mary Kay Ash founded her beauty company more than 56 years ago with three goals: develop rewarding opportunities for women, offer irresistible products, and make the world a better place. That dream has blossomed into a multibillion-dollar company with millions of independent sales force members in nearly 40 countries. Mary Kay is dedicated to investing in the science behind beauty and manufacturing cutting-edge skin care, color cosmetics and fragrances. Mary Kay is committed to empowering women and their families by partnering with organizations from around the world, focusing on supporting cancer research, protecting survivors from domestic abuse, beautifying our communities, and encouraging children to follow their dreams. Mary Kay Ash’s original vision continues to shine—one lipstick at a time. Learn more about Mary Kay at www.marykayglobal.com
About NFTE
Network for Teaching Entrepreneurship (NFTE) is a global nonprofit organization that provides high-quality entrepreneurship education to middle and high school students from under-resourced communities, as well as programs for college students and adults. NFTE will reach 45,000 students this academic year, with programs in 25 states across the U.S. and in 20 additional countries. Since our founding, we have educated more than a million students through in-school, out-of-school, college, and summer camp programs, offered in person and online. To learn more about how we are promoting inclusive capitalism and building the next generation of diverse entrepreneurs, visit www.nfte.com .
View source version on businesswire.com: https://www.businesswire.com/news/home/20211104005178/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
FDA Issues Modified Risk Tobacco Product Orders for 20 ZYN Nicotine Pouch Products30.6.2026 18:19:00 CEST | Press release
FDA’s decision makes ZYN the first nicotine pouch product to receive MRTP orders authorizing reduced-risk claims versus cigarettes Philip Morris International Inc. (PMI) (NYSE: PM) today announced that the U.S. Food and Drug Administration (FDA) issued Modified Risk Tobacco Product (MRTP) orders for 20 variants of ZYN nicotine pouch products. These are the first MRTP orders granted for nicotine pouches, allowing PMI U.S. to market the following claim for the authorized ZYN products: “Using ZYN instead of cigarettes puts you at a lower risk of mouth cancer, heart disease, lung cancer, stroke, emphysema, and chronic bronchitis.” “FDA’s decision is an important moment for the more than 45 million legal-age nicotine consumers in America,” saidStacey Kennedy, PMI U.S. CEO. “Today’s news ensures these adultshave access to accurate, science-based information, including FDA-authorized evidence that switching from cigarettes to ZYN reduces the risk of smoking-related diseases like heart disease
Caidya Announces Strategic Combination with Simbec-Orion Bridging Early Scientific Insight and Global Clinical Execution30.6.2026 17:00:00 CEST | Press release
Caidya today announced a strategic combination with Simbec-Orion designed to close the divide between early scientific insight and global clinical execution. The combination of Caidya and Simbec-Orion creates a differentiated specialty clinical CRO platform that enables programs to scale, maintaining focus, speed, and accountability. The strategic combination brings together complementary strengths to create a more complete development partner for innovative biopharma companies. With established operations across Europe, the Americas, APAC, and China, the combined organization provides meaningful expertise and execution capabilities in the regions that matter most. Simbec-Orion brings early-phase clinical pharmacology capabilities alongside deep therapeutic expertise for later stage complex oncology and rare disease trials, helping sponsors shape critical decisions early in the development lifecycle. Together, the organizations strengthen their ability to support complex, cross-border
Archer® Proves Purpose-Built AI Beats General-Purpose LLMs on Regulatory Change Management: 95% Verified Accuracy, 80x Faster, 92% Lower Cost30.6.2026 16:13:00 CEST | Press release
In a head-to-head benchmark, a leading general-purpose LLM was confidently wrong 35% of the time on regulatory dates. Archer Evolv™ shipped zero errors. For enterprises deploying AI in compliance, a wrong date is a missed deadline. The more dangerous failure is a wrong answer the model returns with high confidence, one that flows silently into a compliance calendar and is only discovered after the window has passed. Archer® today released results showing purpose-built AI beats a general-purpose large language model (LLM) on regulatory work, and it’s not close. This head-to-head test compared Archer’s purpose-built, vertical-specific AI and proprietary data sets against a leading general-purpose LLM, on a core compliance task: determining the publication, effective and comment-close dates of regulatory documents across six jurisdictions. General-purpose models are a genuine breakthrough, and this is no referendum on their quality. The question Archer set out to answer is narrower and mo
Altasciences Supports Key Development Milestone for Steel Therapeutics’ Lead Therapeutic Candidate, Fizurex™30.6.2026 16:08:00 CEST | Press release
Altasciences, a leading drug development organization, today announced a significant milestone in the development of Steel Therapeutics, Inc.’s pivotal toxicology study for its lead product candidate, Fizurex™, for the treatment of anal fissures. The successful completion of the study plays a significant role in the advancement of Fizurex™ toward first-in-human trials. The GLP-compliant study demonstrated a favorable safety profile, which has advanced Steel Therapeutics' plans to submit an Investigational New Drug (IND) application for Fizurex™ to the FDA in Q3 2026. Fizurex™, a patent-pending, single-use topical wipe, was designed to provide a standardized, accessible treatment option for a painful and often undertreated medical condition. The product builds on years of use through compounding pharmacy prescriptions and is now advancing toward clinical development and regulatory review. "We are proud to have supported Steel Therapeutics with the generation of the high-quality safety d
Interactive Brokers Expands Access to Korean Equities with Launch of Nextrade ATS30.6.2026 16:00:00 CEST | Press release
IB SmartRouting℠ Routes Orders to the Best Available Price Between KRX and Nextrade Interactive Brokers (Nasdaq: IBKR), an automated global broker, today announced the launch of select Korean equities through Nextrade, South Korea's first Alternative Trading System (ATS). The addition of Nextrade builds on Interactive Brokers' earlier launch of the Korea Exchange (KRX), through which it became the first major US-based broker to provide global investors with direct access to Korean equities. Clients trading on Nextrade benefit from significantly extended trading hours and access to additional liquidity. Interactive Brokers has enabled IB SmartRouting℠ across both the Korea Exchange (KRX) and Nextrade, automatically routing orders to the venue offering the best price. This helps clients achieve best execution while providing greater flexibility and more opportunities to participate in one of Asia's most dynamic equity markets. Korea's equity market ranks among the top global exchanges by
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
